Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
Patent 5152997 Issued on October 6, 1992. Estimated Expiration Date: 
February 7, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 7, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesTransdermal therapeutic system having improved delivery characteristics Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols Transdermal drug delivery device Externally mounted blown fuse indicator Diffusion matrix for transdermal drug administration and transdermal drug delivery devices including same Patent #: 4911916 InventorsAssigneeApplicationNo. 652127 filed on 02/07/1991US Classes:424/449, Transdermal or percutaneous424/447, Bandages with incorporated medicaments424/448Pressure sensitive adhesive meansExaminersPrimary: Page, Thurman K.Assistant: Horne, Leon R. Attorney, Agent or FirmInternational ClassA61F 013/00AbstractTestosterone is administered transdermally through nonscrotal skin in a manner that mimics in amount and profile the natural production of testosterone in young adult healthy males. The testosterone is administered to the skin from a matrix which contains testosterone at subsaturation concentration and a permeation enhancer.Other References
| |
